Monitoring of Vedolizumab Infusion Therapy (MOVE-IT) Response With Fecal Inflammation Markers, Ultrasound, and Trough Serum Level in Patients With Ulcerative Colitis: Protocol for a Multicentric, Prospective, Noninterventional Study

Jimmi Cording   ^{1 *} , PhD ;   Margit Blömacher   ^{1 *} , PhD ;   Berit Inga Wiebe   ¹ , MSc ;   Jost Langhorst   ² , PhD, MD ;   Torsten Kucharzik   ³ , MD, PhD ;   Andreas Sturm   ⁴ , MD, PhD ;   Stefan Schreiber   ⁵ , MD, PhD ;   Ulf Helwig   ^{5, 6} , MD, PhD

¹ Kompetenznetz Darmerkrankungen eV, Kiel, Germany

² Klinikum Bamberg, Bamberg, Germany

³ Klinikum Lüneburg, Lüneburg, Germany

⁴ DRK Kliniken Berlin | Westend, Berlin, Germany

⁵ University of Kiel, Kiel, Germany

⁶ Medical Practice for Internal Medicine Oldenburg, Oldenburg, Germany

*these authors contributed equally